Herlev og Gentofte Hospital

The trials here

What the 11 trials at this site are about, from their registry records.

Conditions

• Lung cancer5 trials
• Pancreatic cancer3 trials
• Colorectal cancer2 trials
• Chronic kidney disease1 trial
• Heart failure1 trial
• Metastatic breast cancer1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 34 trials
• Phase 12 trials
• Phase 1/22 trials

Status

• Completed5 trials
• Recruiting4 trials
• Active, not recruiting2 trials

Lead sponsor

• Amgen2 trials
• Herlev Hospital2 trials
• Hoffmann-La Roche2 trials
• Cantargia AB1 trial
• Dragonfly Therapeutics1 trial
• and 3 more

Running trials

• Recruiting

  A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants with Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  2024-518365-10-00· Phase 3· F. Hoffmann-La Roche AG· Source

• Recruiting

  Endoscopic Ultrasound-guided Radiofrequency Ablation for Upper Gastrointestinal Tract Lesions

  NCT07272187· Herlev Hospital· Source

  Contact: Bojan Kovacevic, MD, ph.d.

• Recruiting

  The Role of Microbiota in Pancreatic Cancer and Precursor Lesions

  NCT07250100· Herlev Hospital· Source

  Contact: Bojan Kovacevic, MD, ph.d.

• Active, not recruiting

  A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer

  NCT06497556· Phase 3· Hoffmann-La Roche· Source

• Active, not recruiting

  A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)

  NCT06360354· Phase 1· Amgen· Source

• Recruiting

  A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

  NCT04929223· Phase 1· Hoffmann-La Roche· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Lung cancer1 recruiting
• Pancreatic cancer1 recruiting

Closed trials

• Completed

  Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)

  NCT06122961· Novo Nordisk A/S· Source

• Completed

  Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).

  NCT04472429· Phase 3· Incyte Corporation· Source

• Completed

  Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).

  NCT04303780· Phase 3· Amgen· Source

• Completed

  Study of DF1001 in Patients With Advanced Solid Tumors

  NCT04143711· Phase 1/2· Dragonfly Therapeutics· Source

• Completed

  A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors

  NCT03267316· Phase 1/2· Cantargia AB· Source